Generic placeholder image

Current Nutrition & Food Science

Editor-in-Chief

ISSN (Print): 1573-4013
ISSN (Online): 2212-3881

Systematic Review Article

Effects of Vitamin D Status on Inflammatory Markers in Obese Subjects: A Systematic Review

Author(s): Geórgia R.R. de Alencar, Lailton da Silva Freire, Beatriz de Mello Pereira, Verbena R. da Silva, Aline C. Holanda, Rayane C. de Moura, Juliana S. Severo, Debora C. Braz, Dilina do Nascimento Marreiro, Betânia de Jesus e Silva de Almendra Freitas* and Cecília M.R.G. de Carvalho

Volume 16, Issue 3, 2020

Page: [268 - 275] Pages: 8

DOI: 10.2174/1573401315666190311151319

Price: $65

Abstract

Background: Recent studies have demonstrated the role of micronutrients in the manifestation of comorbidities associated with obesity. Vitamin D deficiency, in particular, appears to be associated with increased levels of inflammatory markers, which may lead to chronic low-grade inflammation, elevating the risk of chronic diseases such as diabetes, metabolic syndrome, and cardiovascular disease. The objective of this study was to perform a systematic review of observational studies conducted to investigate the effect of vitamin D deficiency on inflammatory markers in obese subjects.

Methodology: This systematic review was conducted in accordance with the “STROBE” and PRISMA recommendations. Observational studies that evaluated the effect of vitamin D status on inflammatory markers in obese subjects were selected and reviewed. Searches were conducted in the PubMed, SciVerse Scopus, and Web of Science databases from February 21 to 22, 2018.

Results: After the selection and removal of duplicate articles, 10 eligible articles were identified. Results from eight observational studies showed an association between vitamin D deficiency or insufficiency in the body and increased concentrations of inflammatory markers in obese individuals. On the other hand, two of the studies did not demonstrate any correlation. With regard to the inflammatory markers evaluated, eight studies showed high concentrations of ultra-sensitive C-reactive protein, five studies found an increase in interleukin-6 concentrations, and two studies noted increased levels of tumor necrosis factor.

Conclusion: The data presented in this systematic review provide evidence of the association between vitamin D deficiency and increased inflammation in obesity.

Keywords: Adipokines, cytokines, inflammation, interleukins, obesity, vitamin D deficiency, vitamin D insufficiency.

Graphical Abstract
[1]
Arner P, Spalding KL. Fat cell turnover in humans. Biochem Biophys Res Commun 2010; 396(1): 101-4.
[http://dx.doi.org/10.1016/j.bbrc.2010.02.165] [PMID: 20494119]
[2]
Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010; 72(1): 219-46.
[http://dx.doi.org/10.1146/annurev-physiol-021909-135846] [PMID: 20148674]
[3]
Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011; 29(1): 415-45.
[http://dx.doi.org/10.1146/annurev-immunol-031210-101322] [PMID: 21219177]
[4]
Chou CY, Lang HF, Sheu WH, Lin JY. Weight loss improves serum mediators and metabolic syndrome features in android obese subjects. Obes Res Clin Pract 2013; 7(1): e81-8.
[http://dx.doi.org/10.1016/j.orcp.2011.10.003] [PMID: 24331685]
[5]
Ryynänen J, Neme A, Tuomainen TP, et al. Changes in vitamin D target gene expression in adipose tissue monitor the vitamin D response of human individuals. Mol Nutr Food Res 2014; 58(10): 2036-45.
[http://dx.doi.org/10.1002/mnfr.201400291] [PMID: 24975273]
[6]
Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000; 374(2): 334-8.
[http://dx.doi.org/10.1006/abbi.1999.1605] [PMID: 10666315]
[7]
Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96(9): 939-49.
[http://dx.doi.org/10.1161/01.RES.0000163635.62927.34] [PMID: 15890981]
[8]
Gysemans CA, Cardozo AK, Callewaert H, et al. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 2005; 146(4): 1956-64.
[http://dx.doi.org/10.1210/en.2004-1322] [PMID: 15637289]
[9]
Mutt SJ, Karhu T, Lehtonen S, et al. Inhibition of cytokine secretion from adipocytes by 1,25-dihydroxyvitamin D3 via the NF-κB pathway. FASEB J 2012; 26(11): 4400-7.
[10]
Narvaez CJ, Simmons KM, Brunton J, Salinero A, Chittur SV, Welsh JE. Induction of STEAP4 correlates with 1,25-dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue. J Cell Physiol 2013; 228(10): 2024-36.
[http://dx.doi.org/10.1002/jcp.24371] [PMID: 23553608]
[11]
Ding C, Gao D, Wilding J, Trayhurn P, Bing C. Vitamin D signalling in adipose tissue. Br J Nutr 2012; 108(11): 1915-23.
[http://dx.doi.org/10.1017/S0007114512003285] [PMID: 23046765]
[12]
Gao D, Trayhurn P, Bing C. 1,25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. Int J Obes 2013; 37(3): 357-65.
[http://dx.doi.org/10.1038/ijo.2012.53] [PMID: 22508334]
[13]
Rocha LM, Baldan DCS, Souza AL, Chaim EA, Pavin EJ, Alegre SM. Composição corporal e perfil metabólico na deficiência de vitamina D sérica em adultos. Rev Nutr 2017; 30(4): 419-30.
[http://dx.doi.org/10.1590/1678-98652017000400002]
[14]
Al-Sharif FM. Association between insulin resistance and inflammatory cytokines among obese Saudi type 2 diabetic with vitamin D deficiency. Eur J Gen Med 2016; 13(4): 91-6.
[15]
Bellia A, Garcovich C, D’Adamo M, et al. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med 2013; 8(1): 33-40.
[http://dx.doi.org/10.1007/s11739-011-0559-x] [PMID: 21437585]
[16]
Muldowney S, Lucey AJ, Paschos G, et al. Relationships between vitamin D status and cardio-metabolic risk factors in young European adults. Ann Nutr Metab 2011; 58(2): 85-93.
[http://dx.doi.org/10.1159/000324600] [PMID: 21474925]
[17]
Nguyen VT, Li X, Elli EF, et al. Vitamin D, inflammation, and relations to insulin resistance in premenopausal women with morbid obesity. Obesity (Silver Spring) 2015; 23(8): 1591-7.
[http://dx.doi.org/10.1002/oby.21131] [PMID: 26148304]
[18]
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283(15): 2008-12.
[http://dx.doi.org/10.1001/jama.283.15.2008] [PMID: 10789670]
[19]
Guasch A, Bulló M, Rabassa A, et al. Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study. Cardiovasc Diabetol 2012; 11(11): 149.
[http://dx.doi.org/10.1186/1475-2840-11-149] [PMID: 23228198]
[20]
Mangge H, Zelzer S, Meinitzer A, et al. 25OH-vitamin D3 levels in obesity and metabolic syndrome-unaltered in young and not correlated to carotid IMT in all ages. Curr Pharm Des 2015; 21(17): 2243-9.
[http://dx.doi.org/10.2174/1381612821666150105160931] [PMID: 25557634]
[21]
Esteghamati A, Aryan Z, Esteghamati A, Nakhjavani M. Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: associations with inflammatory and cardiometabolic markers in 4391 subjects. Diabetes Metab 2014; 40(5): 347-55.
[http://dx.doi.org/10.1016/j.diabet.2014.02.007] [PMID: 24811744]
[22]
Ilinčić B, Stokić E, Stošić Z, et al. Vitamin D status and circulating biomarkers of endothelial dysfunction and inflammation in non-diabetic obese individuals: a pilot study. Arch Med Sci 2017; 13(1): 53-60.
[http://dx.doi.org/10.5114/aoms.2016.61812] [PMID: 28144255]
[23]
Al Haj Ahmad RM, Al-Domi HA. Vitamin D insufficiency predicts elevated levels of complement 3 independent of insulin resistance and BMI. J Nutr Sci Vitaminol (Tokyo) 2017; 63(3): 155-60.
[http://dx.doi.org/10.3177/jnsv.63.155] [PMID: 28757528]
[24]
Brenner DR, Arora P, Garcia-Bailo B, et al. Plasma vitamin D levels and risk of metabolic syndrome in Canadians. Clin Invest Med 2011; 34(6): E377
[http://dx.doi.org/10.25011/cim.v34i6.15899] [PMID: 22129928]
[25]
Drincic AT, Armas LA, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 2012; 20(7): 1444-8.
[http://dx.doi.org/10.1038/oby.2011.404] [PMID: 22262154]
[26]
Vanlint S. Vitamin D and obesity. Nutrients 2013; 5(3): 949-56.
[http://dx.doi.org/10.3390/nu5030949] [PMID: 23519290]
[27]
Calton EK, Keane KN, Newsholme P, Soares MJ. The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLoS One 2015; 10(11): e0141770
[http://dx.doi.org/10.1371/journal.pone.0141770] [PMID: 26528817]
[28]
de Heredia FP, Gómez-Martínez S, Marcos A. Obesity, inflammation and the immune system. Proc Nutr Soc 2012; 71(2): 332-8.
[http://dx.doi.org/10.1017/S0029665112000092] [PMID: 22429824]
[29]
Earthman CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes 2012; 36(3): 387-96.
[http://dx.doi.org/10.1038/ijo.2011.119] [PMID: 21694701]
[30]
Tabatabaeizadeh SA, Avan A, Bahrami A, et al. High dose supplementation of vitamin D affects measures of systemic inflammation: Reductions in high sensitivity C-reactive protein level and Neutrophil to Lymphocyte Ratio (NLR) distribution. J Cell Biochem 2017; 118(12): 4317-22.
[http://dx.doi.org/10.1002/jcb.26084] [PMID: 28425575]
[31]
Haque UJ, Bathon JM, Giles JT. Association of vitamin D with cardiometabolic risk factors in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012; 64(10): 1497-504.
[http://dx.doi.org/10.1002/acr.21715] [PMID: 22555877]
[32]
Dickie LJ, Church LD, Coulthard LR, Mathews RJ, Emery P, McDermott MF. Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes. Rheumatology (Oxford) 2010; 49(8): 1466-71.
[http://dx.doi.org/10.1093/rheumatology/keq124] [PMID: 20435648]
[33]
Mackawy AMH, Badawi MEH. Association of vitamin D and vitamin D receptor gene polymorphisms with chronic inflammation, insulin resistance and metabolic syndrome components in type 2 diabetic Egyptian patients. Meta Gene 2014; 2(1): 540-56.
[http://dx.doi.org/10.1016/j.mgene.2014.07.002] [PMID: 25606437]
[34]
Lavie CJ, Lee JH, Milani RV. Vitamin D and cardiovascular disease will it live up to its hype? J Am Coll Cardiol 2011; 58(15): 1547-56.
[http://dx.doi.org/10.1016/j.jacc.2011.07.008] [PMID: 21958881]
[35]
Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 2014; 383(9912): 146-55.
[http://dx.doi.org/10.1016/S0140-6736(13)61647-5] [PMID: 24119980]
[36]
Beilfuss J, Jorde R, Kamycheva E. High-sensitivity CRP is associated with serum 25-Hydroxyvitamin D levels, but is not affected by 5-year supplementation with cholecalciferol. J Nutrit Health Food Sci 2017; 5(5): 1-8.
[http://dx.doi.org/10.15226/jnhfs.2017.001108]
[37]
Bouvard B, Annweiler C, Sallé A, et al. Extraskeletal effects of vitamin D: facts, uncertainties, and controversies. Joint Bone Spine 2011; 78(1): 10-6.
[http://dx.doi.org/10.1016/j.jbspin.2010.10.011] [PMID: 21169046]
[38]
Lamendola CA, Ariel D, Feldman D, Reaven GM. Relations between obesity, insulin resistance, and 25-hydroxyvitamin D. Am J Clin Nutr 2012; 95(5): 1055-9.
[http://dx.doi.org/10.3945/ajcn.111.032060] [PMID: 22440850]
[39]
Khoo AL, Chai LY, Koenen HJ, et al. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol 2011; 164(1): 72-9.
[http://dx.doi.org/10.1111/j.1365-2249.2010.04315.x] [PMID: 21323660]
[40]
Gonçalves de Carvalho CM, Ribeiro SML. Aging, low-grade systemic inflammation and vitamin D: a mini-review. Eur J Clin Nutr 2017; 71(4): 434-40.
[http://dx.doi.org/10.1038/ejcn.2016.177] [PMID: 27677370]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy